Today, shares of Xortx Therapeutics Inc opened at $4.00 and closed at $4.07. It traded at a low of $4.00 to a high of $4.17.

The price $verbed percentage_change% from the previous day's close of $4.07.

During the day across North America, the TSX Composite closed tsx_percentage_change% at 21807.37, the S&P 500 closed sp_500_percentage_change% at 4967.23, the Dow Jones Industrial Average closed dow_jones_percentage_change% at 37986.40 and the Nasdaq Composite closed nasdaq_percentage_change% at 15282.01.

Xortx Therapeutics Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker XRTX.

A total of 5,500 shares was traded during the last trading day, with total trades of 31, while having an average volume of 3,363 over the last 5-days.

Trading across the entire TSX-V saw 3,754 price advancers against 1,430 declines and 130 unchanged.

During the prior 52 weeks, XRTX.VN has traded as high as $9.99 (July 27,2023) and low as $2.65 (December 28,2023). Moreover, in the last 52 weeks, Xortx Therapeutics Inc's shares have shrunken -54.32%, while they have boosted 40.34% year-to-date.

Following today's trading, Xortx Therapeutics Inc has a market capitalization of $11.80 million on a float of 2,899 shares outstanding. Its annual EPS is $-3.60.

Xortx Therapeutics Inc is a TSX Biotechnology company headquartered in Calgary, CAN.

Xortx Therapeutics Inc's average recommendation is "Strong Sell" based on 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..